Photo of article from nature.com
Apr 26, 2024, 11:17
Satya Prakash Yadav: Europe in 2022 BMT and Cell Therapy trends
Satya Prakash Yadav, Director of Pediatric Hemato-Oncology and Bone Marrow Transplant at
“Europe in 2022 Bone Marrow Transplant and Cell Therapy trends: In 2022, 46,143 HCT (19,011 (41.2%) allogeneic and 27,132 (58.8%) autologous) in 41,854 patients were reported by 689 European centres.
4329 patients received advanced cellular therapies, 3205 of which were CAR-T. An additional 2854 patients received DLI.”
Read further.
Source: Satya Prakash Yadav/LinkedIn